ADALIMUMAB and PYREXIA

Overview

PYREXIA is the #19 most commonly reported adverse reaction for ADALIMUMAB, manufactured by AbbVie Inc.. There are 18,991 FDA adverse event reports linking ADALIMUMAB to PYREXIA. This represents approximately 1.3% of all 1,482,766 adverse event reports for this drug.

Patients taking ADALIMUMAB who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

PYREXIA is a less commonly reported adverse event for ADALIMUMAB, but still significant enough to appear in the safety profile.

Other Side Effects of ADALIMUMAB

In addition to pyrexia, the following adverse reactions have been reported for ADALIMUMAB:

• DRUG INEFFECTIVE — 90,709 reports
• PAIN — 49,059 reports
• ARTHRALGIA — 48,039 reports
• INJECTION SITE PAIN — 47,251 reports
• FATIGUE — 39,110 reports
• RHEUMATOID ARTHRITIS — 35,572 reports
• HEADACHE — 28,331 reports
• NAUSEA — 27,102 reports
• DIARRHOEA — 25,413 reports
• RASH — 25,268 reports

Other Drugs Associated with PYREXIA

The following drugs have also been linked to pyrexia in FDA adverse event reports:

Does ADALIMUMAB cause PYREXIA?

PYREXIA has been reported as an adverse event in 18,991 FDA reports for ADALIMUMAB. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is PYREXIA with ADALIMUMAB?

PYREXIA accounts for approximately 1.3% of all adverse event reports for ADALIMUMAB, making it a notable side effect.

What should I do if I experience PYREXIA while taking ADALIMUMAB?

If you experience pyrexia while taking ADALIMUMAB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages